Cargando…
Demographic, clinical, and pathological features of early onset pancreatic cancer patients
BACKGROUND: Early onset pancreatic cancer (EOPC), i.e. pancreatic ductal adenocarcinoma (PDAC) occurring in patients below 50 years of age, is rare and there is limited information regarding risk factors, molecular basis and outcome. This study aimed to determine the demographic and clinicopathologi...
Autores principales: | Ntala, Chara, Debernardi, Silvana, Feakins, Roger M., Crnogorac-Jurcevic, Tatjana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136158/ https://www.ncbi.nlm.nih.gov/pubmed/30208959 http://dx.doi.org/10.1186/s12876-018-0866-z |
Ejemplares similares
-
Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis
por: Debernardi, Silvana, et al.
Publicado: (2022) -
Response to the comment on “Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients”
por: Blyuss, Oleg, et al.
Publicado: (2020) -
Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling
por: Alrawashdeh, Wasfi, et al.
Publicado: (2019) -
Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer—A Comprehensive Review
por: Brezgyte, Greta, et al.
Publicado: (2021) -
Nutraceuticals as Supportive Therapeutic Agents in Diabetes and Pancreatic Ductal Adenocarcinoma: A Systematic Review
por: Mikolaskova, Iveta, et al.
Publicado: (2023)